D-0391-2019 Class III Terminated

Recalled by Sun Pharmaceutical Industries, Inc. — Cranbury, NJ

FDA drug recall D-0391-2019 was initiated by Sun Pharmaceutical Industries, Inc. on Dec 26, 2018 and is designated Class III. Reason for recall: Labeling Not Elsewhere Classified: The front panel indicates 24 caplets whereas the side panel indicates 12 caplets. The drug product carton contains 24 caplets. The recall status is terminated (terminated Apr 2, 2020). Affected quantity: 5040 cartons.

Recall Details

Product Type
Drugs
Report Date
Jan 30, 2019
Initiation Date
Dec 26, 2018
Termination Date
Apr 2, 2020
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
5040 cartons

Product Description

LOPERAMIDE HCL TABLETS USP, 2 mg, ANTI-DIARRHEAL, 24 caplets per carton, OTC, Distributed by Drug Mart-Food Fair Medina Ohio 44256 Ohm Laboratories Inc. UPC 0 93351 11270 6 NDC#:53943-123-24

Reason for Recall

Labeling Not Elsewhere Classified: The front panel indicates 24 caplets whereas the side panel indicates 12 caplets. The drug product carton contains 24 caplets.

Distribution Pattern

OH

Code Information

Lot: 2979325, EXP 5/5021

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0391-2019
openFDA file date
Oct 19, 2026
Loaded by RegDataLab
Oct 21, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.